Prot #NU MOF20C02/MCC 20487: Phase I/II Study of Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in the Management of HER2+ Breast Leptomeningeal Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date8/10/21 → 8/10/24

Funding

  • H. Lee Moffitt Cancer Center & Research Institute ((OE) Prot #NU MOF20C02/MCC 20487 // (OE) Prot #NU MOF20C02/MC...)
  • Genentech, Inc ((OE) Prot #NU MOF20C02/MCC 20487 // (OE) Prot #NU MOF20C02/MC...)